Jeffrey Meckler - Jan 18, 2023 Form 4 Insider Report for Indaptus Therapeutics, Inc. (INDP)

Role
CEO and Director, Director
Signature
/s/ Jeffrey Meckler
Stock symbol
INDP
Transactions as of
Jan 18, 2023
Transactions value $
$0
Form type
4
Date filed
1/20/2023, 03:05 PM
Previous filing
Nov 22, 2022
Next filing
May 19, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INDP Stock Option (Right to Buy) Award $0 +100K $0.00 100K Jan 18, 2023 Common Stock 100K $1.61 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests and becomes exercisable as to one-third of the total shares on January 18, 2024 and thereafter in equal quarterly installments over the following 24 months, such that the stock option becomes vested and exercisable as to all shares on January 18, 2026.